Muscarinic antagonist

	WikiDoc Resources for Muscarinic antagonist
Articles
Most recent articles on Muscarinic antagonist Most cited articles on Muscarinic antagonist Review articles on Muscarinic antagonist Articles on Muscarinic antagonist in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Muscarinic antagonist Images of Muscarinic antagonist Photos of Muscarinic antagonist Podcasts & MP3s on Muscarinic antagonist Videos on Muscarinic antagonist
Evidence Based Medicine
Cochrane Collaboration on Muscarinic antagonist Bandolier on Muscarinic antagonist TRIP on Muscarinic antagonist
Clinical Trials
Ongoing Trials on Muscarinic antagonist at Clinical Trials.gov Trial results on Muscarinic antagonist Clinical Trials on Muscarinic antagonist at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Muscarinic antagonist NICE Guidance on Muscarinic antagonist NHS PRODIGY Guidance FDA on Muscarinic antagonist CDC on Muscarinic antagonist
Books
Books on Muscarinic antagonist
News
Muscarinic antagonist in the news Be alerted to news on Muscarinic antagonist News trends on Muscarinic antagonist
Commentary
Blogs on Muscarinic antagonist
Definitions
Definitions of Muscarinic antagonist
Patient Resources / Community
Patient resources on Muscarinic antagonist Discussion groups on Muscarinic antagonist Patient Handouts on Muscarinic antagonist Directions to Hospitals Treating Muscarinic antagonist Risk calculators and risk factors for Muscarinic antagonist
Healthcare Provider Resources
Symptoms of Muscarinic antagonist Causes & Risk Factors for Muscarinic antagonist Diagnostic studies for Muscarinic antagonist Treatment of Muscarinic antagonist
Continuing Medical Education (CME)
CME Programs on Muscarinic antagonist
International
Muscarinic antagonist en Espanol Muscarinic antagonist en Francais
Business
Muscarinic antagonist in the Marketplace Patents on Muscarinic antagonist
Experimental / Informatics
List of terms related to Muscarinic antagonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview[edit | edit source]

A muscarinic receptor antagonist is an agent that reduces the activity of the muscarinic acetylcholine receptor. Most of them are synthetic, but scopolamine atropine are belladonna alkaloids, and are naturally extracted.

Important^[1] muscarinic agonists include atropine, hyoscine, ipratropium, tropicamide, cyclopentolate and pirenzepine.

Comparison table[edit | edit source]

Substance	Trade names	Mechanism^[2]	Clinical use^[2]	Adverse effects^[2]
Atropine (D/L-Hyoscyamine)		non-selective antagonism, CNS stimulation	in anaesthesia anticholinesterase poisoning bradycardia antispasmodic in gastrointestinal hypermotility	urinary retention xerostomia blurred vision
Scopolamine (L-Hyoscine)		non-selective antagonism, CNS depression	as atropine motion sickness	as atropine sedation
Ipratropium		non-selective antagonism, without any mucociliary excretion inhibition.	in asthma and bronchitis
Tropicamide		short acting non-selective antagonism, CNS depression	produce mydriasis and cycloplegia in diagnostics	may cause ocular hypertension
Pirenzepine		M1 receptor-selective antagonist inhibits gastric secretion	in peptic ulcer (not much anymore)	(fewer than non-selective ones)
Diphenhydramine	Benadryl
Dimenhydrinate	Dramamine
dicyclomine
flavoxate
oxybutynin
tiotropium	Spiriva
cyclopentolate		short acting non-selective antagonism, CNS depression	produce mydriasis and cycloplegia in diagnostics	may cause ocular hypertension
atropine methonitrate		non-selective antagonism, blocks transmission in ganglia	antispasmodic in gastrointestinal hypermotility
trihexyphenidyl	Artane
tolterodine	Detrusitol
solifenacin	Vesicare
darifenacin	Enablex
benztropine	Cogentin

References[edit | edit source]

↑ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 147
↑ ^2.0 ^2.1 ^2.2 Unless else specified in table boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 147

External links[edit | edit source]

http://cvpharmacology.com/antiarrhy/atropine.htm
Muscarinic+antagonists at the US National Library of Medicine Medical Subject Headings (MeSH)

Template:Drugs for functional gastrointestinal disorders

Template:Mydriatics and cycloplegics Template:Receptor agonists and antagonists

Template:Jb1 Template:WH Template:WS

[Rang147-1] Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 147

[Rang147Unless-2] 2.0 ^2.1 ^2.2 Unless else specified in table boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 147

[1]

[2]

v t e Urologicals (G04)
Acidifiers	Ammonium chloride, Calcium chloride
Urinary antispasmodics (primarily antimuscarinics)	Darifenacin, Emepronium, Fesoterodine, Flavoxate, Meladrazine, Oxybutynin, Propiverine, Solifenacin, Terodiline, Tolterodine, Trospium
For erectile dysfunction	prostaglandins: Alprostadil PDE5 inhibitors: Avanafil - Sildenafil - Tadalafil - Udenafil - Vardenafil alpha blockers: Moxisylyte - Phentolamine - Yohimbine others: Apomorphine - Papaverine
Other urologicals	Acetohydroxamic acid, Collagen, Dimethyl sulfoxide, Magnesium hydroxide, Pentosan polysulfate, Phenazopyridine, Phenyl salicylate, Succinimide
For benign prostatic hypertrophy	5α-reductase inhibitors: Dutasteride, Finasteride Alpha blockers: Alfuzosin, Doxazosin, Silodosin, Tamsulosin, Terazosin Herbals: Pygeum africanum, Serenoa repens

Muscarinic antagonist

Contents

Overview[edit | edit source]

Comparison table[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

External links[edit | edit source]